Photo

613.801.1061

...

Ottawa

English

Andrew Masson

Articling Student

Andrew is an articling student at MBM’s Ottawa office.

Andrew obtained his JD from Osgoode Hall Law School in 2024. Upon graduation, he was awarded the IP Osgoode David Vaver Medal for Excellence in Intellectual Property Law for outstanding achievement in intellectual property law or policy.

While at Osgoode, Andrew completed the Intellectual Property Law & Technology Intensive Program, where he was placed with CIPO (Canadian Intellectual Property Office) in their policy division. Andrew also competed with Osgoode’s team in the USPTO Competitive Patent Drafting Moot, winning bronze in the regional rounds.

Andrew was a member of the Osgoode Hall Law Journal throughout his 3 years at law school, finishing his final year as the Director of Production. He also wrote for the IPilogue (Osgoode’s IP blog) and was a Fellow with the IP Innovation Clinic, a student-based clinic designed to provide assistance to under-resourced inventors and start-ups.

In 2022, prior to law school, Andrew completed his PhD in Ecology and Evolutionary Biology from the University of Toronto. As part of his PhD thesis, Andrew examined how the proximate mechanisms that control animal behaviour at a mechanical level can explain the emergence of animal behaviours.

As a former professional lacrosse player, Andrew enjoys staying active and playing lacrosse whenever he can.

Education

  • JD - Osgoode Hall Law School (2024)
  • Ph.D., Ecology and Evolutionary Biology - University of Toronto (2022)
  • M.Sc., Ecology and Evolutionary Biology - University of Toronto (2015)
  • B.Sc., Biological Sciences - University of Vermont (2013)

cb photo 104 561d6c7777c80

SCOTT MILLER

Partner


Scott is driven by his business approach to resolving disputes including a no nonsense style dictated by enormous energy and passion.
MBM read_more_btn

 

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More